Deep Brain Stimulation (DBS)

When oral medications and botulinum toxin are no longer enough to manage a child’s generalized dystonia, Deep Brain Stimulation (DBS) may be the next step as an elective option for chronic management. DBS is often described as a “brain pacemaker” ^[1]. It involves a surgical procedure to place thin wires, called leads, into a specific part of the brain called the globus pallidus pars interna (GPi) ^[2]. These leads are connected to a battery (the neurostimulator) implanted under the skin of the chest, which sends electrical pulses to the brain to disrupt the abnormal signals causing the dystonia ^[1][2].

When to Consider DBS

DBS is generally considered for children whose dystonia is severe, disabling, and “pharmaco-refractory”—meaning it has not responded well enough to medication trials ^[1][2].

A critical shift in medical thinking recognizes an observational association where earlier intervention may yield better outcomes, prompting early discussion, though it is not a universal consensus or automatic indication for surgery ^[3]. Evidence suggests that a shorter duration of the disease before surgery is associated with better long-term outcomes ^[3][4].

• The Window of Opportunity: Specialists aim to intervene before the constant muscle pulling causes fixed contractures (joints that are permanently stuck) or significant skeletal deformities like scoliosis ^[5][6]. DBS does not reverse established contractures.
• Preserving Mobility: For progressive conditions like KMT2B-related dystonia, data supports considering DBS while the child can still walk, as it may help preserve that ability or even help some children regain it, though response is highly variable and walking preservation is not guaranteed ^[5].
• Status Dystonicus: In rare cases involving GNAO1 variants, status dystonicus is managed acutely with emergency stabilization and intensive care; DBS is not an immediate rescue procedure for this crisis, but rather a planned option for selected, refractory chronic movement disorders ^[7][8].

Outcomes by Genetic Type

The underlying genetic cause of the dystonia is one of the strongest predictors of how well DBS will work, though response varies substantially ^[9][10].

• TOR1A (DYT1): This group typically sees the most robust and stable improvements, with some studies reporting over 70% improvement in motor scores that lasts for a decade or more ^[10].
• KMT2B: While many children see meaningful benefits—especially in the neck and trunk—the response is often more variable (around 30–40% improvement), and some symptoms like speech or gait may continue to be challenging ^[10][11].

Long-Term Realities and Hardware

DBS is not a “one and done” procedure; it requires lifelong management of the hardware, and the intracranial procedure itself carries risks including hemorrhage, stroke, seizure, anesthesia complications, and lead-placement problems ^[12].

• Hardware Revisions: Some cohorts report that about 36% of children with DBS will require a follow-up operation at some point, often due to a “fracture” in the wire or the lead moving out of place as the child grows ^[12][13].
• Infection Risks: Roughly 10% of patients in some studies experience a surgical site infection, which sometimes requires the entire system to be temporarily removed ^[13]. Note: These figures vary widely by age, center, device, and definition of revision. Families should ask their treating center for its own pediatric data.
• Battery Life: Depending on the settings, non-rechargeable batteries need replacement surgery every few years. Rechargeable systems last much longer but require the family to “charge” the child’s chest battery regularly ^[13].

Potential Side Effects

While DBS is primarily used to improve movement, the stimulation itself can sometimes cause “stimulation-induced” side effects.

• Speech and Swallowing: Some children may experience bradylalia (slowed speech) or changes in voice quality after the system is turned on ^[14][11].
• Movement Changes: In some cases, children may develop parkinsonism—a mild “slowness” of movement (bradykinesia)—that was not present before ^[14][11].

These side effects are often manageable by “programming”—adjusting the electrical settings of the device—but they underscore the need for regular follow-up with a specialist team that includes neurologists, neurosurgeons, and speech therapists ^[15][16]. Expect multiple programming visits and a gradual recovery.